The effects of Bleomycin A5 on infantile maxillofacial haemangioma

Head and Face Medicine

Volumn 7, Issue 1, 2011, Pages

  Luo, Quan Feng ^a   Zhao, Fu Yun ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; BLEOMYCIN A5; DRUG DERIVATIVE;

ARTICLE; COMPARATIVE STUDY; DOSE RESPONSE; FACE TUMOR; FEMALE; HEMANGIOMA; HUMAN; INFANT; INTRALESIONAL DRUG ADMINISTRATION; MALE; MAXILLA TUMOR; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FACIAL NEOPLASMS; FEMALE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRALESIONAL; MAGNETIC RESONANCE IMAGING; MALE; MAXILLARY NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960029955     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-7-11     Document Type: Article

References (10)

1. Pienaar C, Graham R, Geldenhuys S, et al. Intralesional Bleomycin for the Treatment of Hemangiomas. Plast Reconstr Surg 2006, 117:221-226. 10.1097/01.prs.0000194906.61805.b0, 16404271.
2. Omidvari S, Nezakatgoo N, Ahmadloo N, et al. Role of intralesional bleomycin in the treatment of complicated hemangiomas: prospective clinical study. Dermatol-Surg 2005, 31(5):499-501.
3. Muir T, Kirsten M, Fourie P, et al. Intralesional bleomycin injection (IBI) treatment for haemangiomasand congenital vascular malformations. Pediatr Surg Int 2004, 19:766-773. 10.1007/s00383-003-1058-6, 14740248.
4. Ming L. Structure and Function of Metalloantibiotics. Medicinal Research Reviews 2003, 23(6):697-762. 10.1002/med.10052, 12939790.
5. Marek J. Ostrowski An Assessment of the Long-Term Results of Controlling the Reaccumulation of Malignant Effusions Using lntracavity Bleomycin. Cancer 1986, 57:721-727. 10.1002/1097-0142(19860215)57:4<721::AID-CNCR2820570407>3.0.CO;2-5, 2417681.
6. Shastri S, Slayton RE, Wolter J, Perlia CP, et al. Clinical study with bleomycin. Cancer 1971, 28:1142-1146. 10.1002/1097-0142(1971)28:5<1142::AID-CNCR2820280509>3.0.CO;2-A, 4108197.
7. Jensen JL, Goel R, Venner PM. The Effect of Corticosteroid Administration on Bleomycin Lung Toxicity. Cancer 1990, 65:1921-1927.
8. Poetke M, Philipp CM, Urban P, Berlien H. Laser Therapy of Haemangiomas and Vascular Malformations-Techniques and Strategies. Medical Laser Application 2004, 19(1):32-44.
9. Hohenleutner S, Badur-Ganter E, Landthaler M, Hohenleutner U. Long-Term Results in the Treatment of Childhood Hemangioma With the Flashlamp-Pumped Pulsed Dye Laser: An Evaluation of 617 Cases. Lasers in Surgery and Medicine 2001, 28:273-277. 10.1002/lsm.1050, 11295764.
10. Al-Sebeih K, Manoukian J. Systemic steroids for the management of obstructive subglottic haemangioma. The Journal of Otolaryngology 2000, 29(6):361-366.